Catabasis Pharmaceuticals Inc (CATB) stock is down -36.40% over the last 12 months, and the average rating from Wall Street analysts is a Hold. InvestorsObserver’s proprietary ranking system, gives CATB stock a score of 7 out of a possible 100.
That rank is mainly influenced by a fundamental score of 0. CATB's rank also includes a short-term technical score of 9. The long-term technical score for CATB is 11.
What's Happening with CATB Stock Today
Catabasis Pharmaceuticals Inc (CATB) stock has risen 10.66% while the S&P 500 is down -0.12% as of 3:13 PM on Friday, Feb 19. CATB has risen $0.34 from the previous closing price of $3.19 on volume of 6,879,687 shares. Over the past year the S&P 500 has gained 15.89% while CATB is down -36.40%. CATB lost -$2.14 per share in the over the last 12 months.
Click Here to get the full Stock Score Report on Catabasis Pharmaceuticals Inc (CATB) Stock.
